Invitation

Scientific Programme

General Information

Accreditation

Wed 19.03 – Fri 21.03.2025

City: London

Type of event: on site

Invitation

Dear Colleagues

It is a pleasure to announce the 2nd Postgraduate Course in Cardiometabolic Medicine, a timely and highly acclaimed educational programme conceived by Zurich Heart House – London Heart House, King’s College, and Royal Brompton & Harefield Hospitals, which will address an unmet educational need.

Cardiometabolic disorders represent a cluster of interrelated risk factors, primarily dyslipidemia, hypertension, elevated fasting blood glucose, obesity and non-alcoholic steatohepatitis. A combination of several of these risk factors massively increases the incidence and mortality of coronary heart disease and stroke. The strong association between metabolic disorders and cardiovascular health delivers a compelling reason to improve awareness of this cluster by identifying the risk factors and inducing targeted interventions.

The Postgraduate Course in Cardiometabolic Medicine consists of a three-day programme. State of the art lectures alternate with a great variety of interactive sessions, including workshops, rapid fire sessions and hands-on imaging sessions.

The course offers a unique opportunity to become an expert in the seminal area of cardiometabolic medicine. We are looking forward to receiving your application and meeting you in London.
Sincerely,

Andrew Krentz
Thomas F. Lüscher
Mahmoud Barbir
John E. Deanfield
Michael Papadakis
Naveed Sattar 

---

Scientific Programme

Tuesday, April 30^th, 2024 (UK time)

Venue: The Royal Society of Medicine

09:00 – 09:30 | REGISTRATION AND COFFEE
09:30 – 9:45 | Opening Session
09:30	Welcome by the course directors & Course concept and structure

09:45 – 11:30 | Session 1: Obesity I- Causes and mechanisms Chairs: Barbara McGowan & Michael Papadakis
09:45	Is obesity a disease? If so, how do we diagnose it? The ESC’s view	Konstantinos Koskinas, Berne
10:05	Obesity and inflammation	Nikolaus Marx, Aachen
10:25	What links adiposity to CVD?	Naveed Sattar, Glasgow
10:45	The gut microbiome: a new risk factor for obesity and CVD	Thomas F. Lüscher, London
11:05	Panel discussion
11:30 – 12:00 | COFFEE

12:00 – 12:30 | Keynote lecture
	Medical management of obesity: GLP-1/GIP agonists	John E. Deanfield, London

12:00 – 13:30 | Session 2: Obesity II – Management Chairs: Naveed Sattar & Thomas F. Lüscher
12:30	Behavioural management: Nutrition	Michael Lean, Glasgow
12:50	Bariatric surgery: is there still a role?	Barbara McGowan, London
13:10	Panel discussion
13:30 – 14:15 | Industry Sponsored Symposium
14:15 – 15:00  |  LUNCH BREAK

15:00 – 16:20 | Session 3: ASCVD Assessment I Chairs: Mahmoud Barbir & Thomas F. Lüscher
15:00	Cardiovascular risk assessment: the ESC SCORE/SCORE2-OP The ESC Guidelines	François Mach, Geneva
15:20	LDL-C and cardiovascular disease: Why is lower better?	Lale Tokgozolu, Ankara
15:40	Lifetime risk: CVD prevention – personal and national strategy	John E. Deanfield, London
16:00	Panel discussion
16:20 – 16:45 | COFFEE

16:45 – 17:45 | Case-based interactive seminars I
	How to assess adiposity: Clinical, MRI and beyond	Geltrude Mingrone, London
	How to manage obesity	Barbara McGowan, London
17:45 | End of day 1

DAY 2, Thursday, March 20th, 2024

09:00 – 10:30 | Session 4: ASCVD Assessment II & Management Chairs: Lale Tokgözoğlu & NN
09:00	Multimodality imaging to assess ASCVD	Leon Menezes, London
09:20	Perivascular fat: Therapeutic target or surrogate of vascular disease?	Charalambos Antoniades, Oxford
09:40	siRNA for LDL-C and Lipoprotein(a)	Ulf Landmesser, Berlin
10:00	Remnant cholesterol and triglycerides in cardiovascular disease	Borge Nordestgaard, Copenhagen
10:20	Panel discussion
10:45 – 11:15 | COFFEE

11:15 – 12:15 | Live demonstrations
	Practical lipid apheresis	Mahmoud Barbir, London/
	Pulse wave velocity and central blood pressure measurement – Practical demonstration	Christian Heiss, Guildford
12:15 – 13:00 | Industry Sponsored Symposium
13:00 – 13:45 | LUNCH

13:45 – 15:10 | Session 5: Diabetes mellitus (DM) Chairs: Eleanor Wicks & William Alazawi
13:45	Pathogenesis of type 2 DM	Janaka Karaliedde, London
14:05	Diabetes Type 2 and CVD beyond glucocentricity	Stephan Jacob, Villingen
14:25	Management of CVD risk in type 2 diabetes – the 2023 ESC Diabetes guidelines	Katharina Schütt, Aachen
14:45	Panel discussion

15:10 – 16:10 | Session 6: Nephrology – Chronic Kidney Disease (CKD) – Causes & Mechanisms   Chairs: Christoph Wanner & Katharina Schütt
15:10	CKD and cardiovascular risk	William Herrington, Oxford
15:30	Albuminuria, eGFR slopes and outcomes: impact of pharmacotherapy	David Wheeler, London
15:50	Panel discussion
16:10 – 16:30 | COFFEE

16:30 – 17:10 | Session 7: Nephrology – Chronic kidney disease (CKD) – Management  Chairs: Thomas Lüscher & NN
16:30	SGLT2i and GLP1-RA in CKD and DKD – the 4 pillar approach	Christoph Wanner, Würzburg
16:50	MR antagonists and CKD: effects and management of hyperkalaemia	Faiez Zannad, Nancy
17:10	Panel discussion

17:30 – 18:30  |  Case-based interactive seminars II
	Managing type 2 diabetes and CVD risk	Stephan Jacob, Villingen
	Managing patients with CKD	Christoph Wanner, Würzburg
17:45 | End of day 2

DAY 3, Friday, March 21st, 2024

09:00 – 10:00 | Session 8: Metabolic dysfunction-associated steatotic liver disease (MASLD)  Chairs: Andrew Krentz & Geltrude Mingrone
09:00	Screening and diagnosis of MASLD	Philip Newsome, London
09:20	Management of MAFLD	William Alazawi, London
09:40	Panel discussion

10:00 – 11:00 | Session 9: Endocrinology and Cardiovascular disease  Chairs: NN & NN
10:00	Cardiovascular risk in classic endocrine disease	Adrian Heald, Manchester
10:20	Sex hormones and CVD: Men vs Women	Andrew Krentz, London
10:40	Panel discussion
11:00 – 11:30 | COFFEE

11:30 – 12:30 | Session 10: Amyloid heart disease  Chairs: Eleanor Wicks & Nikant Sabharwal
11:30	The spectrum of amyloid heart disease	Julian Gillmore, London
11:50	Diagnosis and management of cardiac amyloidosis	Marianna Fontana, London
12:10	Panel discussion
12:30 – 13:15 | Industry Sponsored Symposium
13:15 – 14:00 | LUNCH

14:00 – 15:00 | Session 11: Heart failure   Chairs: Eleanor Wicks & Shanti Velmurugan
14:00	Prevention of heart failure	Pardeep Jhund, Glasgow
14:20	Comorbidities of heart failure: obesity, diabetes and renal failure	Mark Petrie, Glasgow
14:40	Management of heart failure: the 2021 and 2023 ESC guidelines	Theresa McDonagh, London
15:00	Panel discussion
15:30 – 16:00 | COFFEE

16:00 – 17:00 | Case-based interactive seminars III
	Diagnosing MASLD with abdominal ultrasound	Kevin Moore, London
	Diagnosing HFpEF, HFrEF and diabetic heart disease with echocardiography	Alison Duncan, London
17:00 | End of day 3

---

General Information

Registration

Category
Registration fees
Regular fee	GBP 750
Early registration fee (until March 1, 2024)	GBP 600
Trainees/Residents, Research fellows, Nurses, Students <40 years (ID proof required)*	GPB 550
Day Tickets	GPB 250

*For the reduced registration (Trainees/Residents, Research fellows, Nurses, Students <40 years) please send a copy of your ID to Ms. Christine Lohmann at christine.lohmann@zhh.ch

Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.

Modification & Cancellation

All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to Zurich Heart House. For each modification requested by the participant, GBP 15 will be charged for administrative costs. In case of cancellation up to March 1st, 2025, deposits will be refunded less 35% for administrative costs. After this date, no refund will be possible.

Venue

The Royal Society of Medicine,
1 Wimpole St, Marylebone, London W1G 0AE, United Kingdom

Organisation

Zurich Heart House, / London Heart House, Foundation for Cardiovascular Research
Eleanor Wicks
Christine Lohmann
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95 
www.zhh.ch / www.londonhearthouse.uk 

---

Accreditation

The Postgraduate Course in Cardiometabolic Medicine will be submitted to the

• Federation of the Royal Colleges of Physicians of the United Kingdom
• European Accreditation Council for Continuing Medical Education (EACCME)

---

Teaching Faculty

---

Under the Auspices of

In collaboration with